Zonisamide (BluePoint Laboratories)
Welcome to the PulseAid listing for the Zonisamide drug offered from BluePoint Laboratories. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BluePoint Laboratories |
NON-PROPRIETARY NAME: | Zonisamide |
SUBSTANCE NAME: | ZONISAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Sulfonamides [Chemical/Ingredient],Carbonic Anhydrase Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-03-13 |
END MARKETING DATE: | 0000-00-00 |
Zonisamide HUMAN PRESCRIPTION DRUG Details:
Item Description | Zonisamide from BluePoint Laboratories |
LABELER NAME: | BluePoint Laboratories |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2014-03-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68001-242_0ce0b804-4309-467b-9eb4-16b28eda70d2 |
PRODUCT NDC: | 68001-242 |
APPLICATION NUMBER: | ANDA077651 |
Other ZONISAMIDE Pharmaceutical Manufacturers / Labelers: